CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Planned sale CEO and President sold 8,552 shares at $1.35 ($11,545)
- 4 Planned sale Young Teresa L. sold 2,907 shares at $1.35 ($3,924)
- 4 Planned sale Chief Financial Officer sold 4,066 shares at $1.35 ($5,489)
- 4 Planned sale Chief Legal Officer and EVP sold 4,156 shares at $1.35 ($5,611)
- 4 Planned sale Ege David S. sold 4,066 shares at $1.35 ($5,489)
- 4 Planned sale von Moltke Lisa sold 4,232 shares at $1.35 ($5,713)
- 4 Planned sale Henn Matthew R. sold 3,886 shares at $1.35 ($5,246)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Ege David S. sold 7,038 shares at $5.19 ($36,527)
- 4 Grant or award Chief Financial Officer acquired 42,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 19 · 380 filings